Avalon Care Center Honolulu: Medication, Care Lapses - HI
HONOLULU, HI - Federal inspectors found significant medication management violations and inadequate rehabilitation services at Avalon Care Center during an April 2025 inspection, raising concerns about patient safety and quality of care.
Medication Safety Violations Put Residents at Risk
During the inspection, healthcare surveyors discovered serious medication management deficiencies that compromised patient safety protocols. In one documented case, a registered nurse failed to properly account for narcotic medications, specifically oxycodone, which could potentially enable drug diversion or create dosing errors.
Inspectors found discrepancies in the controlled substance tracking system on medication cart 1C. The narcotic log indicated 24 oxycodone tablets should have been available for one resident, but only 22 tablets were physically present. The nurse revealed she had administered one pill at 9:18 AM but failed to immediately document it in the controlled drug record, and had also dropped and wasted another tablet without proper documentation.
This violation directly contradicted the facility's own policies, which require nurses to immediately document controlled substances when removing doses from storage. The Director of Nursing confirmed that narcotics should be signed out upon preparation, not after administration, to prevent medication tracking errors.
Proper narcotic management protocols exist to prevent medication diversion and ensure accurate dosing. Federal regulations require strict accountability for controlled substances because they carry high abuse potential and can cause serious harm if mismanaged. When nurses fail to document narcotic administration immediately, it creates opportunities for medications to be lost, stolen, or administered incorrectly.
Expired and Discontinued Medications Found on Patient Carts
Inspectors also discovered expired and discontinued medications remaining on medication carts, creating additional safety hazards. On cart 2B, surveyors found a half-filled bottle of ferrous gluconate that had expired in March 2025, along with methocarbamol tablets belonging to a resident who had been discharged from the facility.
The methocarbamol had been discontinued on February 28, 2025, but remained on the medication cart for over a month. The associated resident had been discharged on March 17, 2025, yet their medication was still present during the April inspection. An Assistant Director of Nursing acknowledged that all medications should have been removed from carts when discontinued and properly disposed of according to facility protocols.
Leaving expired or discontinued medications accessible creates multiple risks. Expired medications may lose potency or develop harmful breakdown products. Discontinued medications could be inadvertently administered to the wrong patient, potentially causing adverse drug reactions or therapeutic conflicts with current treatments.
Inadequate Pharmacist Recommendations Implementation
The facility failed to properly implement pharmacist recommendations for high-risk medication monitoring. During a March 2025 medication review, the consulting pharmacist provided specific monitoring guidelines for a resident taking multiple high-risk medications, including aspirin, diabetes medications, and opioid pain relievers.
The pharmacist recommended monitoring for bleeding and bruising due to antiplatelet therapy, hypoglycemia and hyperglycemia related to diabetes medications, and constipation and sedation from opioid use. While the facility acknowledged receiving these recommendations, they failed to incorporate them into physician orders or establish formal monitoring protocols.
Monthly pharmacist reviews serve as a critical safety net in nursing home care. These reviews help identify potentially dangerous drug interactions, inappropriate dosing, and necessary monitoring parameters. When facilities fail to implement pharmacist recommendations, residents face increased risks of adverse drug events, hospitalizations, and complications from unmonitored medication effects.
Federal regulations require facilities to document rationale when they choose not to implement pharmacist recommendations. This facility provided no documentation explaining why they ignored important safety monitoring guidelines.